FinTechsDepot FinTechsDepot - Empowering FinTech Futures: Where Knowledge Fuels Innovation.

  • HOME
  • ARTICLES
    • Digital banking
  • RESOURCES
    • Whitepaper
    • Infographics
  • GLOBENEWSWIRE NEWS
  • EVENTS
    • Upcoming conference
    • Past Conference
    • Webinar
  • Contact Us
FinTechsDepot
  • Home
  • Admin
  • Page 32

Author

Admin 422 posts 0 comments

Articles

FinTech Funding Frenzy: BankTech Ventures Backs Three Innovative Startups

Admin Dec 10, 2024
The winds of change are blowing through the financial services industry, and FinTech startups are at the forefront…
Whitepaper

UiPath Automation Suite Security, Privacy, and Compliance

Admin Dec 3, 2024
UiPath offers multiple delivery options to meet a wide variety of needs, including policy and security…
Infographics

B2b Payments Fintech: Empowering Business Transactions

Admin Dec 2, 2024
B2B Payments Fintech has revolutionized business transactions by streamlining processes, expediting payments, and…
Whitepaper

“Supercharge Your Credit Card Program”

Admin Nov 29, 2024
Struggling to keep your credit card program profitable? Discover why many leaders are turning to the agent issuing…
Whitepaper

Digital Banking—Why is it Becoming so Important to Financial Organizations?

Admin Nov 28, 2024
Over thirty years ago, people were talking about technology transformation in banking. Today, everyone is talking…
Whitepaper

“Generative AI Trends Among U.S. Financial Advisors and Consumers”

Admin Nov 27, 2024
Discover the latest insights on how financial advisors and their clients embrace generative AI. This report dives…
Featured News

Merchants Bancorp Closes Depositary Share Offering

Admin Nov 26, 2024
CARMEL, Ind., Nov. 25, 2024 /PRNewswire/ — Merchants Bancorp (“Merchants”) (Nasdaq: MBIN), parent company of…
Whitepaper

“Generative AI Trends Among U.S. Financial Advisors and Consumers”

Admin Nov 25, 2024
Generative AI is making a substantial impact on U.S. financial advisors and their clients. With 82.5% of advisors…
Whitepaper

“Navigating the Financial Landscape: Predictions and Insights for Financial…

Admin Nov 22, 2024
Market research can make or break your strategies -- understand the trends shaping banking right now. Today's…
Past Conference

Americas Lending Day 2024

Admin Nov 21, 2024
Join Finastra for the Americas Lending Day on November 13, 2024, in New York City. This in-person event will…
Older Posts
Newer Posts

    SUBSCRIBE NOW


    Via Email
    Via Telephone


    I Agree. I would like to share my information with FinTechsDepot & their partners so that I can receive relevant information about products, services, & offers.

    RECENT POST

    • Understanding Credit Card Losses: Causes, Prevention, and Recovery
    • Everything You Should Know About Contactless Payments
    • Embedded banking but not as you know it
    • How Smart Money Management and Digital Trends Are Reshaping Wealth in 2026
    • INVESTMENT GUIDE Investing for your future

    ARTICLE

    Historical DNA connects 1.3 million living relatives to 17th-century Maryland settlers and may have identified the colony’s second governor
    2026-05-14T18:16:01Z
    Analysis of Historic St. Mary’s City highlights the power of combining ancient DNA, archaeology, and genealogy to restore lost identities and track the migrations of America's earliest English colonists and...


    Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
    2026-05-14T18:00:00Z
    WILMETTE, Ill., May 14, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs,...


    Award-Winning Film ‘An Inconvenient Study’ Being Blocked By Verizon
    2026-05-14T17:11:17Z
    ICAN Investigates Reports That Verizon Customers Are Unable to Access AnInconvenientStudy.com


    Adaptin Bio Shares (Ticker: APTN) Commence Trading on the OTCQB
    2026-05-14T17:05:00Z
    CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by targeted delivery to the...


    Rarecells Recognized Among Top 5 Disruptive Health Technologies with the Potential to Change the World by Maynooth University’s Innovation Value Institute
    2026-05-14T16:11:34Z
    NEW YORK and PARIS, May 14, 2026 (GLOBE NEWSWIRE) -- Rarecells, a pioneer in liquid biopsy technologies for early cancer detection, today announced that its proprietary ISET® diagnostic system has...


    Imviva Biotech Presents Data Demonstrating Durable Clinical Responses from Ongoing Phase 1/2 Study of CTA313 in Systemic Lupus Erythematosus at ASGCT 2026
    2026-05-14T15:43:11Z
    100% of patients treated with CTA313 achieved an SRI-4 response, with half achieving remission


    Terumo Neuro Announces Publication of Landmark RAGE Study Results for HydroCoil™ Embolic System Coils for Ruptured Intracranial Aneurysms
    2026-05-14T15:29:00Z
    Largest prospective, core lab–adjudicated trial in North America confirms strong occlusion, low rebleeding, and favorable functional independence


    DentPrime Introduces an “International Complication Protection Program” for Overseas Dental Patients
    2026-05-14T15:00:00Z
    New initiative to increase patient confidence and long-term aftercare support in international dental treatment


    Zealand Pharma - Transactions related to share buy-back program (weeks 19-20, 2026)
    2026-05-14T15:00:00Z
    Company announcement No. 16 / 2026


    ORYZON Reports Financial Results and Corporate Update for Quarter Ended March 31st, 2026
    2026-05-14T14:47:26Z
    MADRID and CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial...


    Tessera Therapeutics Showcases New Preclinical Data Advancing In Vivo Program in Sickle Cell Disease and CAR-T Applications at the American Society of Gene and Cell Therapy 29th Annual Meeting
    2026-05-14T14:20:08Z
    SOMERVILLE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Tessera Therapeutics (“Tessera”), the biotechnology company pioneering a new approach in genetic medicine known as Gene Writing™, is presenting updates across its...


    Inner Voyage Recovery Center launches virtual intensive outpatient program for Georgia and beyond
    2026-05-14T14:00:00Z
    Woodstock rehab brings structured addiction treatment to patients who can't access in-person treatment — wherever they are.


    Lanier Recovery Center opens its doors in Suwanee, Georgia, bringing comprehensive addiction treatment to the Atlanta region
    2026-05-14T14:00:00Z
    Lanier Recovery Center opens in Suwanee to give Atlanta-area individuals and families a trusted local resource for addiction treatment and mental health care.


    NFL Hall of Famer Brett Favre Reports Significant Parkinson's Medication Reduction as Zhittya Genesis Medicine Marks Four Years of Parkinson’s Research
    2026-05-14T14:00:00Z
    The three-time NFL MVP, Super Bowl XXXI Champion, and former Green Bay Packers quarterback says he has been treated twice with Zhittya's investigational biologic and has "significantly" reduced his dopamine...


    Red Ribbon Recovery Colorado now offers virtual addiction treatment to patients across the United States
    2026-05-14T14:00:00Z
    Addiction and mental health treatment, delivered virtually across the U.S.


    ApolloMD Recognized as One of the Best Places to Work in Healthcare in 2026
    2026-05-14T13:35:31Z
    ATLANTA, May 14, 2026 (GLOBE NEWSWIRE) -- ApolloMD has been selected by Modern Healthcare 2026 Best Places to Work in Healthcare, recognizing healthcare organizations that foster strong workplace culture, support...


    Silexion Therapeutics Reports Positive Preliminary Immunotherapy Findings for SIL204 in KRAS-Driven Pancreatic Cancer
    2026-05-14T13:27:00Z
    Preliminary results from a preclinical study demonstrated statistically significant increase in MHC-I expression following SIL204 treatment in human pancreatic and non-small cell lung cancer cells harboring a KRAS mutation, supporting...


    TOMI Environmental Solutions, Inc. Announces Second SteraMist Hybrid System Installation Contract with a World-Renowned East Coast Research University
    2026-05-14T13:20:00Z
    FREDERICK, Md., May 14, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announce that we have been awarded the...


    Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
    2026-05-14T13:15:00Z
    Company selected as Best Pediatric Lysosomal Storage Disease Therapeutics and Rare Neurodegenerative Disease Drug Development Excellence Award Winner


    Sonablate Launches SONA FUSION Global Registry to Advance Precision Sound Medicine and Define Future Standards in Focal Therapy
    2026-05-14T13:03:00Z
    First multinational initiative dedicated to long-term HIFU outcomes in prostate cancer and BPH aims to help close the evidence gap in incision-free prostate care


    CJ Biomaterials Launches New Home Compostable all-PHA Extrusion Coating Resin for Paper Food Serviceware
    2026-05-14T13:00:00Z
    WOBURN, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- CJ Biomaterials, Inc., a division of South Korea-based CJ CheilJedang and a primary producer of polyhydroxyalkanoate (PHA) biopolymers, has announced the commercial...


    Syneos Health Expands Strategic AI Partnerships to Advance Commercial Precision Performance
    2026-05-14T13:00:00Z
    MORRISVILLE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Syneos Health® today announced new and expanded strategic partnerships that strengthen its cutting-edge, AI ecosystem. These innovative solutions represent best-in-breed technologies that...


    Curanex Reports First Quarter 2026 Business Progress as Phyto-N Advances Toward Planned FDA Submission
    2026-05-14T12:53:00Z
    Completed GMP manufacturing and toxicology milestones supporting planned Q4 2026 IND submission for ulcerative colitis


    Administrative Experience Emerges as Key Pressure Point for Self-Funded Plans, Brighton Health Plan Solutions Survey Finds
    2026-05-14T12:45:00Z
    New report shows employee satisfaction remains high, but trust can break down when administrative friction gets in the way


    Senti Biosciences Holdings Reports First Quarter 2026 Financial Results and Highlights Advancement of SENTI-202 Program into Pivotal Phase
    2026-05-14T12:45:00Z
    Secured strategic financing vehicle for up to $40 million Positive FDA feedback supports single-arm pivotal trial for potential registration of SENTI-202 in initial indication of Relapsed/Refractory Acute Myeloid Leukemia (R/R...


    AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer
    2026-05-14T12:41:00Z
    Positive Data from Named Patient Program and Positive Interim Data from Ongoing Phase 2 Clinical Trial


    Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program
    2026-05-14T12:40:00Z
    Following a Type B meeting with FDA, Senti Bio plans to proceed with a single-arm multi-center registrational trial for SENTI-202, building off the strong Phase 1 clinical results demonstrating deep...


    Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers
    2026-05-14T12:40:00Z
    Terreplenish® leads the way as company responds to worldwide nitrogen shortage


    GRI Bio Reports First Quarter 2026 Financial Results, New Data Reinforcing Differentiated Profile of GRI-0621 in Idiopathic Pulmonary Fibrosis and Highlights Continued Advancement of Differentiated Immune-Modulating Pipeline
    2026-05-14T12:35:00Z
    Phase 2a data show zero cough and 60% lower treatment-related diarrhea than placebo despite higher nintedanib use in the active arm – suggesting GRI-0621 may mitigate nintedanib-related GI-toxicities when used...


    Biogen Completes Acquisition of Apellis Pharmaceuticals
    2026-05-14T12:35:00Z
    CAMBRIDGE, Mass., May 14, 2026 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the successful completion of the acquisition of Apellis Pharmaceuticals, Inc. (Nasdaq: APLS). Apellis, a leader in...

    Copyright © 2026 | FinTechsDepot | All Rights Reserved |
    Privacy Policy | Unsubscribe
    Sign in

    Welcome, Login to your account.

    Forget password?
    Sign in

    Recover your password.

    A password will be e-mailed to you.